Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 566

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 566
---
    | $ | 25,451 | ​ | ​ | ​ | ​        | ​ | -95%  | ​ | ​ | ​ | ​                              | $ | 32,634 | ​ | ​ | ​ | ​    | $ | 80,095 | ​ | ​ | ​ | ​        | ​ | -59% | ​ | ​ |

General and Administrative Expenses

| ​                                              
 ​                                              
 ​                                              | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Three Months EndedSeptember 30, 
 2024                            
 Dollar amounts in thousands     |   |       |   | ​ | ​ | 2023 |   |       |   | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | ​        
 % change 
 ​        | ​ 
 ​ | ​    
 ​    | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Nine Months EndedSeptember 30, 
 2024                           
 Dollar amounts in thousands    |   |        |   | ​ | ​ | 2023 |   |        |   | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | ​        
 % change 
 ​        | ​ 
 ​ | ​    
 ​    | ​ 
 ​ | ​ 
 ​ 
 ​ |
|:-----------------------------------------------|:--|:--|:--------------------------------|:--|------:|:--|:--|:--|:-----|:--|------:|:--|:--|:--|:---------|:--|:-----|:--|:--|:--|:-------------------------------|:--|-------:|:--|:--|:--|:-----|:--|-------:|:--|:--|:--|:---------|:--|:-----|:--|:--|
| Professional fees and public/investorrelations | ​ | ​ | ​                               | $ | 1,451 | ​ | ​ | ​ | ​    | $ | 1,485 | ​ | ​ | ​ | ​        | ​ | -2%  | ​ | ​ | ​ | ​                              | $ |  3,583 | ​ | ​ | ​ | ​    | $ |  4,925 | ​ | ​ | ​ | ​        | ​ | -27% | ​ | ​ |
| Stock-based compensation                       | ​ | ​ | ​                               | ​ | 1,473 | ​ | ​